Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

Eli Lilly introduced Mounjaro, a diabetes and weight-loss drug, in India, aiming to tackle obesity and diabetes. With a ...

Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard ...

Eli Lilly India launches Mounjaro, a first-of-its-kind medication for obesity and type 2 diabetes, offering hope for millions ...

Eli Lilly and Company (India) has launched 'Mounjaro,' a novel medication for obesity and type 2 diabetes, after receiving ...

The higher the BMI, the more a person is at risk of heart disease and type 2 diabetes.However, a new study has found that BMI ...

Global pharmaceutical company Eli Lilly and Company (India) has introduced Mounjaro (tirzepatide) in India, a breakthrough ...

A higher BMI is consistently associated with longer operative times and increased complications across a wide range of ...

BOISE — A Senate committee on Tuesday narrowly advanced a bill to prohibit candy and soda purchases on SNAP food assistance.

Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country's ...

Data from the Centers for Disease Control and Prevention (CDC) shows that Texas has a higher obesity rate than the national average. It’s one of the reasons why the Academy of Nutrition and ...